Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (7345)	4/4/1999 11:56:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

The Big Pharma Report: 4/04/99 Have PFun! BigKNY3 ________________________________________________________ Big Pharma Scoreboard 4/01/99 -AMGN remains the star of Big Pharma in 1999 -PFE continues to show impressive gains versus the market -WLA is still suffering the Rezulin blues -GLX and SBH both jumped on merger talks... Don't bet on it happening. . Price % Chg % Chg % Chg Rank . 04/01/99 Week March YTD 1999 1 Amgen 76.88 3.0% 19.9% 47.0% 2 Amer 66.50 -0.3% 9.7% 18.0% 3 J&J 94.13 3.1% 9.5% 12.2% 4 Pfizer 139.56 3.4% 5.2% 11.7% 5 Pharma 62.56 1.2% 14.4% 10.5% 6 Merck 79.94 -0.5% -1.7% 8.4% 7 Smith 72.81 9.3% 0.5% 4.8% 8 Glaxo 69.94 13.1% 4.5% 0.6% 9 Scher 55.31 -0.7% -0.8% 0.1% 10 Lilly 86.88 2.9% -10.2% -2.3% 11 Abbott 47.56 1.6% 1.1% -2.9% 12 Bristol 63.19 6.2% 1.8% -5.6% 13 Warner 66.00 -2.5% -3.7% -12.2% Big Pharma 75.48 3.0% 3.4% 6.4% Dow 9,786 -0.4% 5.1% 6.6% S&P 500 1,286 0.2% 3.9% 4.6% NASDAQ 2,461 1.7% 7.6% 12.2% News/chart/quote links to Big Pharma and ED stocks: Yahoo! PFE News biz.yahoo.com Five Day Chart of PFE versus the Dow quicken.com A great PFE Stat Website dailystocks.com Labpuppy.com Drug Stock Commentary (scroll down after opening) labpuppy.com A New Investment Website Worth A Try bridge.com Big Pharma Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com ED Stocks Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com The 1999 Pharma Portfolio Challenge: Motley Fool /SI Challenge Highlights -Ron Flanagan (+22.1) remains #1 with an equal trifecta of PFE/MRK/AMGN (Portfolio: 33% PFE/MRK/AMGN, 1% Cash). -MBTAY (+20.5%) moved up to second place (Portfolio: 75% PFE, 25% AMGN) -McMenus(+19.7%) is in the place position (Portfolio: 40% PFE, 25% AMGN/MRK, 10%:JNJ) -The top 6 places have AMGN in their portfolios. -The five 100% PFErs (+11.7%) moved up to 12th place (Portfolio: 100% PFE) -Supporting the principles behind the Peabody Model: PEABODY PURCHASE (+4.9%) is beating the PFE DRIP (+2.4%). Both portfolios are weighed down due to their large cash accounts in the growing Big Pharma market. -The PFE DRIP and PFE DRIP SHORT added 5.91 shares@141.03 on 3/31/99 -SHORT COX II (-10.0%) is in 64th place (Portfolio: 50% short PFE; 50% short MRK) -SHORT PFE (-11.7%) is the new cellar dweller (Portfolio: 100% short PFE) -PFE DRIP SHORT (-0.3%) is now slightly in the red (Portfolio: 76% in cash, 24% in shorting PFE at monthly DRIP prices)